WLLW

Willow Biosciences (WLLW)

Willow Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:TSX:WLLW

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/13	20 : 00	PR Newswire (US)	WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	TSX:WLLW	Willow Biosciences Inc
2024/05/13	20 : 00	PR Newswire (Canada)	WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	TSX:WLLW	Willow Biosciences Inc
2024/03/29	08 : 30	PR Newswire (Canada)	WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF	TSX:WLLW	Willow Biosciences Inc
2024/03/29	08 : 30	PR Newswire (US)	WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF	TSX:WLLW	Willow Biosciences Inc
2024/03/01	08 : 00	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSEC	TSX:WLLW	Willow Biosciences Inc
2024/03/01	08 : 00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSEC	TSX:WLLW	Willow Biosciences Inc
2024/02/21	08 : 00	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
2024/02/21	08 : 00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
2024/01/31	21 : 00	PR Newswire (US)	WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	TSX:WLLW	Willow Biosciences Inc
2024/01/31	21 : 00	PR Newswire (Canada)	WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT	TSX:WLLW	Willow Biosciences Inc
2024/01/16	21 : 00	PR Newswire (US)	WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
2024/01/16	21 : 00	PR Newswire (Canada)	WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
2024/01/10	21 : 00	PR Newswire (US)	WILLOW PLANS FOR SIGNIFICANT GROWTH IN 2024 ON THE BACK OF A SUCCESSFUL 2023	TSX:WLLW	Willow Biosciences Inc
2024/01/10	21 : 00	PR Newswire (Canada)	WILLOW PLANS FOR SIGNIFICANT GROWTH IN 2024 ON THE BACK OF A SUCCESSFUL 2023	TSX:WLLW	Willow Biosciences Inc
2023/12/07	21 : 00	PR Newswire (US)	WILLOW AND LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY ADVANCE DEVELOPMENT PROGRAM TO MANUFACTURE SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
2023/12/07	21 : 00	PR Newswire (Canada)	WILLOW AND LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY ADVANCE DEVELOPMENT PROGRAM TO MANUFACTURE SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
2023/10/11	08 : 52	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING	TSX:WLLW	Willow Biosciences Inc
2023/10/11	08 : 52	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING	TSX:WLLW	Willow Biosciences Inc
2023/10/03	20 : 00	PR Newswire (US)	WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION	TSX:WLLW	Willow Biosciences Inc
2023/10/03	20 : 00	PR Newswire (Canada)	WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION	TSX:WLLW	Willow Biosciences Inc
2023/10/03	16 : 00	PR Newswire (US)	WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION	TSX:WLLW	Willow Biosciences Inc
2023/09/12	20 : 00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES COMPANY INSIDER LED CONVERTIBLE DEBENTURE FINANCING	TSX:WLLW	Willow Biosciences Inc
2023/09/06	20 : 00	PR Newswire (Canada)	WILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D PROGRAM ON COST-EFFECTIVE, SUSTAINABLY PRODUCED UDCA	TSX:WLLW	Willow Biosciences Inc
2023/09/06	20 : 00	PR Newswire (US)	WILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D PROGRAM ON COST-EFFECTIVE, SUSTAINABLY PRODUCED UDCA	TSX:WLLW	Willow Biosciences Inc
2023/08/30	20 : 00	PR Newswire (US)	WILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COST	TSX:WLLW	Willow Biosciences Inc
2023/08/30	20 : 00	PR Newswire (Canada)	WILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COST	TSX:WLLW	Willow Biosciences Inc
2023/08/24	20 : 00	PR Newswire (US)	WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND FOCUS ON BIOOXI PLATFORM	TSX:WLLW	Willow Biosciences Inc
2023/08/24	20 : 00	PR Newswire (Canada)	WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND FOCUS ON BIOOXI PLATFORM	TSX:WLLW	Willow Biosciences Inc
2023/08/21	20 : 00	PR Newswire (US)	WILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc
2023/08/21	20 : 00	PR Newswire (Canada)	WILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTS	TSX:WLLW	Willow Biosciences Inc